NCT04509466 2024-03-07Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCLCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1/2 Terminated41 enrolled
NCT00788125 2023-07-14Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsCity of Hope Medical CenterPhase 1/2 Terminated7 enrolled 9 charts
NCT04602065 2023-03-15Evaluation of Safety and Efficacy of IBI318 Monotherapy for Relapsed/Refractory Extranodal NK/T Cell Lymphoma (Nasal Type) TrialInnovent Biologics (Suzhou) Co. Ltd.Phase 1/2 Terminated9 enrolled
NCT01805037 2021-09-01Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ LymphomasNorthwestern UniversityPhase 1/2 Terminated20 enrolled 17 charts
NCT00625729 2017-12-28Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic LeukemiaMasonic Cancer Center, University of MinnesotaPhase 1/2 Terminated6 enrolled 10 charts